Tag: Covid-19
-

Single Sensor to Detect Covid-19, Flu in Works
A university engineering team is developing an electronic sensor to quickly detect and distinguish between Covid-19 and influenza viruses.
-

Fast Covid-19 Antibody Test Gets BARDA Funds
A company developing point-of-care diagnostics is receiving a federal government contract for a one-drop blood test that detects Covid-19 virus antibodies in five minutes.
-

Covid-19 Vaccine and Therapy Tracker Designed
A science graphics software company offers an online dashboard for tracking development of vaccines and therapies for Covid-19 infections.
-

Open-Source N95 Respirator Mask in the Works
An engineering partnership is designing a 3-D printed medical face mask needed by front-line health care workers, with its specifications soon to be made freely available.
-

Infographic – Steps to Control Covid-19 Transmission
The Lancet prepared a chart with the most effective measures for controlling person-to-person transmission, reproduced as this weekend’s infographic.
-

Convalescent Plasma Found Safe as Covid-19 Therapy
Donated blood plasma from people who recovered from Covid-19 infections is found to cause few serious side effects when given as a treatment for infections in others.
-

Program Reduces Long-Term Care Covid-19 Outbreaks
A collaborative program between an academic medical center and long-term care homes for older residents helps reduce Covid-19 infection outbreaks and deaths.
-

Covid-19 Dual Therapy Drug Trial Okayed
A company developing an oral drug that treats both Covid-19 infections and overactive immune system reactions received regulatory approval for a later-stage clinical trial.
-

Partnership to Speed Covid-19 Clinical Trials
A company that aims to accelerate clinical trials is partnering with an entrepreneur and researcher to speed up the pace of new trials of Covid-19 vaccines, therapies, and diagnostics.
-

Infographic – Covid-19 Hurting Local Businesses
The chart draws its data from a report by J.P. Morgan Chase on declines in local business volumes as a result of Covid-19 lock-downs.